Telomir Pharmaceuticals, Common Stock Analysis

Telomir Stock Analysis Notes

About 43.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.63. Telomir Pharmaceuticals, had not issued any dividends in recent years. To find out more about Telomir Pharmaceuticals, Common contact Erez Aminov at 813-864-2558 or learn more at https://telomirpharma.com.

Telomir Pharmaceuticals, Investment Alerts

Telomir Pharmaceuticals, Thematic Classifications

Telomir Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 179.73 M.

Telomir Profitablity

Management Efficiency

Telomir Pharmaceuticals, has return on total asset (ROA) of (0.8449) % which means that it has lost $0.8449 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.8691) %, meaning that it created substantial loss on money invested by shareholders. Telomir Pharmaceuticals,'s management efficiency ratios could be used to measure how well Telomir Pharmaceuticals, manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -2.88. In addition to that, Return On Capital Employed is likely to grow to -1.09. At this time, Telomir Pharmaceuticals,'s Total Assets are very stable compared to the past year. As of the 29th of November 2024, Non Current Assets Total is likely to grow to about 5.2 M, while Other Assets are likely to drop (44.7 K).

Technical Drivers

As of the 29th of November, Telomir Pharmaceuticals, has the Variance of 54.76, risk adjusted performance of 0.0027, and Coefficient Of Variation of (12,176). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telomir Pharmaceuticals,, as well as the relationship between them.

Telomir Pharmaceuticals, Price Movement Analysis

Telomir Pharmaceuticals, Insider Trading Activities

Telomir Pharmaceuticals, Predictive Daily Indicators

Telomir Pharmaceuticals, Corporate Filings

Telomir Pharmaceuticals, Forecast Models

Telomir Pharmaceuticals,'s time-series forecasting models are one of many Telomir Pharmaceuticals,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telomir Pharmaceuticals,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Telomir Pharmaceuticals, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telomir shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telomir Pharmaceuticals,. By using and applying Telomir Stock analysis, traders can create a robust methodology for identifying Telomir entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.